Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kristen Alexander Insider Profile
4 Followers
Kristen Alexander, VP, Finance and Accounting at Lexicon Pharmaceuticals, holds 47.80K shares in Lexicon Pharmaceuticals (Ticker: LXRX).
Kristen Alexander has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kristen Alexander's holdings
Insider Roles
VP, Finance and Accounting
Roles that Kristen Alexander holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kristen Alexander
Kristen Alexander's Trading History
List of latest transactions for each holding click on a transaction to see Kristen Alexander's performance on stock
You May Also Like
Kristen Alexander insider profile FAQ
What is the percentage of profitable transactions made by Kristen Alexander?
The percentage of profitable transactions made by Kristen Alexander is ―.
What is the average return per transaction made by Kristen Alexander?
The average return per transaction made by Kristen Alexander is ―.
What stocks does Kristen Alexander hold?
Kristen Alexander holds: LXRX stocks.
What was Kristen Alexander’s latest transaction?
Kristen Alexander latest transaction was an Uninformative Buy of $30.90K.
What was Kristen Alexander's most profitable transaction?
Kristen Alexander’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kristen Alexander's role in Lexicon Pharmaceuticals?
Kristen Alexander's role in Lexicon Pharmaceuticals is VP, Finance and Accounting.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.